In this study, the polymorphisms of the HLA DMA and DMB genes in patients w
ith rheumatoid arthritis (RA) were examined.
DMA and DMB typing was performed in 120 white RA patients from eastern Fran
ce and 100 healthy controls, using PCR-SSO (sequence specific oligonucleoti
de probes) method for DMA determination and PCR-RI;LP (restriction fragment
: length polymorphism) method for DMB typing. All patients and controls had
been HLA DRB1* genotyped.
DMA*0103 was found significantly increased in RA patients (RA vs, controls:
18.3% vs. 4%) (p(corr) = 0.004; OR: 5.39; CI: 1.67-19.23). A decreased fre
quency of DMA*0102 was also observed in the RA group (RA vs. controls: 18.3
% vs. 31%), bur not significantly. There were no differences in the prevale
nce of DMB alleles between RA and controls. The patients and the controls w
ere then stratified according to the expression of the HLA DRB1* RA-linked
alleles (DRB1*01 and *04) and this allowed us to find no linkage disequilib
rium between DMA*0103 and DRB1*01 or *04 alleles. Finally, most DMA*0103 pa
tients were positive for rheumatoid factors and had extraarticular involvem
ent such as subcutaneous nodules.
Thus, our results suggest that DMA*0103 could be an additional genetic fact
or for RA susceptibility in French whites. (C) American Society for Histoco
mpatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.